Mail

UK markets closed

FTSE 100
8,164.12
-15.56(-0.19%)
FTSE 250
20,286.03
-45.77(-0.23%)
AIM
764.38
-0.09(-0.01%)
GBP/EUR
1.1796
-0.0009(-0.07%)
GBP/USD
1.2648
+0.0006(+0.05%)
Bitcoin GBP
48,012.73
-986.66(-2.01%)

8 UK holiday home businesses you could buy now

A holiday let could be a very sound investment, providing a decent income, capital growth and — somewhere to escape

EZZ Life Science Holdings Limited (EZZ.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

1.8450

+0.2550

(+16.04%)

At close: 04:10PM AEST

Currency in AUD

Valuation measures⁴

Market cap (intra-day)	81.94M
Enterprise value	69.63M
Trailing P/E	22.67
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.80
Price/book (mrq)	5.36
Enterprise value/revenue	1.59
Enterprise value/EBITDA	13.97

Trading information

Stock price history

Beta (5Y monthly)	0.52
52-week change ³	272.73%
S&P500 52-week change ³	22.55%
52-week high ³	1.8500
52-week low ³	0.4500
50-day moving average ³	1.0567
200-day moving average ³	0.7212

Share statistics

Avg vol (3-month) ³	108.11k
Avg vol (10-day) ³	162.72k
Shares outstanding ⁵	44.41M
Implied shares outstanding ⁶	44.41M
Float ⁸	11.53M
% held by insiders ¹	73.24%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.03
Forward annual dividend yield ⁴	1.36%
Trailing annual dividend rate ³	0.01
Trailing annual dividend yield ³	0.63%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	24.32%
Dividend date ³	N/A
Ex-dividend date ⁴	16 May 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	7.94%
Operating margin (ttm)	6.88%

Management effectiveness

Return on assets (ttm)	15.56%
Return on equity (ttm)	24.87%

Income statement

Revenue (ttm)	43.73M
Revenue per share (ttm)	1.02
Quarterly revenue growth (yoy)	43.40%
Gross profit (ttm)	N/A
EBITDA	4.42M
Net income avi to common (ttm)	3.47M
Diluted EPS (ttm)	0.0800
Quarterly earnings growth (yoy)	-12.10%

Balance sheet

Total cash (mrq)	12.62M
Total cash per share (mrq)	0.29
Total debt (mrq)	304.32k
Total debt/equity (mrq)	1.99%
Current ratio (mrq)	3.92
Book value per share (mrq)	0.36

Cash flow statement

Operating cash flow (ttm)	4.32M
Levered free cash flow (ttm)	3.31M